Jyong Biotech - נכסים נקיים למניה בודדת MENS
The linear price action on the Jyong Biotech Ltd (MENS) chart correlates with the implementation of digital algorithms for laboratory sample analysis, where the indicator stands at -0.34. The company's revenues are based on the sale of phytotherapeutic agents, including the promising MCS-2 drug for BPH. Meanwhile, the business relies on ESG principles, employing eco-friendly extraction and responsible harvesting of plant raw materials to create its medications.
jyongbio.com - פילוחים אנליטיים ומדדי מפתח (MENS)
Book value determines the intrinsic stability of Jyong Biotech Ltd (MENS) through the volume of net assets. This metric is calculated by dividing shareholders' equity by the number of shares outstanding, reflecting the actual value of the assets. The BVPS trend allows for the verification of accounting accuracy between reporting periods. Growth in this indicator confirms effective capital management, which is further supported by the optimization of pharmaceutical substance logistics, ensuring high supply profitability.